Phase 3 Clinical Trial of Teriparatide in Japan

NCT00433160 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Teriparatide
DRUG: Placebo

Sponsor

Eli Lilly and Company